companies / apreohealth-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-16 json
| total_raised | 130,000,000130.0M | ○ |
|---|---|---|
| founded | 2020 | |
| hq | Menlo Park, US | |
| industry | unknown | |
| stage | series-b+ |
Apreo Health is developing investigational medical devices for treating chronic lung disease. It serves pulmonologists and patients with severe respiratory conditions in clinical research today. The pipeline targets a market dominated by valves and stents rather than introducing new mechanical concepts.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-08-01 | series-b | 130,000,000130.0M | null | ○ |
Nginx, WordPress 7.0, jQuery Migrate 3.4.1, imagesLoaded 5.0.0, Elementor 4.0.8, Python, PHP, MySQL, jquery 3.
| fact | status | src |
|---|---|---|
| Series B, $130.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |